Deep Vein Thrombosis
USMLE Step 1 trap: Overvalues Homans sign as a diagnostic test for DVT when it is neither sensitive nor specific. Homans sign has poor sensitivity and specificity for DVT and should not be used to confirm or exclude the diagnosis.
Deep vein thrombosis is a clot in the deep venous system, most commonly in the proximal leg veins (popliteal, femoral, iliac). It matters on USMLE Step 1 primarily because of its relationship to pulmonary embolism — proximal DVT is the source of most clinically significant PEs. The exam tests DVT both as a standalone diagnosis and as context for PE risk, so you need to understand it from presentation through management. Expect questions that give you a clinical vignette and ask you to interpret exam findings, select the right diagnostic test, or choose treatment duration.
What makes DVT tricky is that the clinical exam is notoriously unreliable, and Step 1 exploits this. Students who memorized Homans sign in anatomy lab treat it like a useful test — the exam will punish that. The diagnosis section is also a favorite place to test D-dimer misuse: students know it's 'the DVT test' but get the direction wrong, using a positive result to confirm disease rather than a negative result to exclude it. The Wells score framework (pre-test probability → D-dimer vs. ultrasound) is the core diagnostic logic you need to know.
Management questions on USMLE Step 1 almost always hinge on one variable: was the DVT provoked or unprovoked? Duration of anticoagulation depends entirely on this distinction, and the exam loves to give you a post-op DVT and see if you default to indefinite therapy. Know your anticoagulant options (DOACs first-line, LMWH for cancer), and know that 3 months is the answer for a clear provoked event.
Common misconceptions
What the exam tests
- Recognize that classic DVT signs (swelling, erythema, warmth, tenderness) and physical exam maneuvers like Homans sign are unreliable — the exam tests whether you know clinical findings alone cannot confirm or exclude DVT.
- Apply the Wells DVT clinical decision rule to stratify pre-test probability, then use D-dimer (to rule out in low-probability patients) or compression ultrasound (to rule in) appropriately — the exam tests the correct sequence and what each test tells you.
- Select the correct anticoagulant and treatment duration based on DVT context: 3 months for provoked DVT, extended or indefinite therapy for unprovoked DVT or cancer-associated DVT, with DOACs as first-line and LMWH preferred in malignancy.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →